<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-1593</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИНФАРКТ МИОКАРДА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MYOCARDIAL INFARCTION</subject></subj-group></article-categories><title-group><article-title>Сравнительный анализ интрамиокардиальной аутологичной трансплантации постнатальных стволовых клеток из периферической крови и жировой ткани у больных в остром периоде инфаркта миокарда с подъемом сегмента ST после эффективной тромболитической реперфузии и стентирования коронарных артерий</article-title><trans-title-group xml:lang="en"><trans-title>Comparative analysis of intramyocardial autotransplantation of postnatal stem cells from peripheral blood and adipose tissue in patients with acute phase of myocardial infarction, ST segment elevation, after effective thrombolytic reperfusion and coronary artery stenting</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Харламов</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kharlamov</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"/><email xlink:type="simple">dr_kharlamov@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смоленская</surname><given-names>О. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Smolenskaya</surname><given-names>O. G.</given-names></name></name-alternatives><bio xml:lang="ru"/><email xlink:type="simple">dr_kharlamov@bk.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Габинский</surname><given-names>Я. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Gabinsky</surname><given-names>Ya. L.</given-names></name></name-alternatives><bio xml:lang="ru"/><email xlink:type="simple">dr_kharlamov@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бос</surname><given-names>Э. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Bos</surname><given-names>E. K.</given-names></name></name-alternatives><bio xml:lang="ru"/><email xlink:type="simple">dr_kharlamov@bk.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГУЗ СО Клинико-диагностический центр «Кардиология», Екатеринбург</institution></aff><aff xml:lang="en"><institution>Clinical and Diagnostic Center “Cardiology”, Yekaterinburg</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ООО Городская больница №41, Екатеринбург</institution></aff><aff xml:lang="en"><institution>City Clinical Hospital No. 41, Yekaterinburg</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Медицинский центр Университета Гронинген, Гронинген</institution></aff><aff xml:lang="en"><institution>Medical Center, Groningen University, Groningen</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>01</day><month>01</month><year>1970</year></pub-date><volume>6</volume><issue>8</issue><fpage>52</fpage><lpage>59</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Харламов А.Н., Смоленская О.Г., Габинский Я.Л., Бос Э.К., 1970</copyright-statement><copyright-year>1970</copyright-year><copyright-holder xml:lang="ru">Харламов А.Н., Смоленская О.Г., Габинский Я.Л., Бос Э.К.</copyright-holder><copyright-holder xml:lang="en">Kharlamov A.N., Smolenskaya O.G., Gabinsky Y.L., Bos E.K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/1593">https://cardiovascular.elpub.ru/jour/article/view/1593</self-uri><abstract><p>Цель. Сравнительный анализ различных техник трансплантации стволовых клеток (СК) из периферической крови и жировой ткани для определения наиболее оптимального метода в остром периоде инфаркта миокарда (ИМ). Материал и методы. В исследование включены 90 больных с острым ИМ. Пациенты были рандомизированы на 3 группы: основная (n=31), группа сравнения (n=27) и группа контроля (n=32). Пациенты основной группы через 1 сутки после рандомизации в течение 5 дней получали комбинированную терапию цитокинами, трансплантацию СК путем зондирования артерий на 6-9 сутки после рандомизации. Больным из группы сравнения трансплантировали мезенхимальные СК, полученные из жировой ткани. В группе контроля пациенты получали только стандартную терапию. Контроль исследуемых показателей осуществляли до трансплантации, через 1, 3, 6 и 12 месяцев после рандомизации. Результаты. В группе сравнения более быстро увеличилась сократительная способность миокарда, однако в отдаленном периоде это преимущество отсутствовало. Глобальная сократимость миокарда увеличилась в среднем на 25,2% (p&lt;0,05) в основной группе и группе сравнения; в группе контроля она уменьшилась в среднем на 29,4% (p&lt;0,05). За 12 месяцев после острого ИМ изменился ФК ХСН в среднем с 2,8 до 1,1 в основной группе (p&lt;0,05); с 2,9 до 1,3 в группе сравнения (p&lt;0,05); в группе контроля – с 2,7 до 2,2 (p&lt;0,05). Через 12 месяцев в основной группе случаи смертельного исхода отсутствовали, в группе сравнения – 1 случай; в группе контроля – 10 (p&lt;0,05). Через 12 месяцев объем рубца в основной группе составлял 5,7% массы левого желудочка, в группе сравнения – 7,5%, в группе контроля – 42,3%. Заключение. Аутологичная трансплантация СК из периферической крови и жировой ткани является высоко эффективным и безопасным методом лечения острого ИМ.</p></abstract><trans-abstract xml:lang="en"><p>Aim. To compare various techniques of peripheral blood and adipose tissue stem cell (SC) transplantation and identify its optimal method for acute phase of myocardial infarction (MI). Material and methods. The study included 90 patients with acute MI. The participants were randomized into three groups: main group (n=31), comparison group (n=27), and control group (n=32). Main group received five-day combined cytokine therapy, starting 24 hours after randomization; at Day 6-9 after randomization, SC transplantation was performed by artery catheterization. Comparison group received adipose tissue mesenchymal SC. Control group was administered standard therapy only. All assessed parameters were measured before transplantation, and 1, 3, 6, and 12 months after randomization. Results. In comparison group, myocardial contractility increased more rapidly in the short term, but not in the long-term follow-up. Global myocardial contractility increased by 25,2% (p&lt;0,05) in main and comparison groups; in control group, it decreased by 29,4% (p&lt;0,05). During 12 months after acute MI, КС of CHF had increased from 2,8 to 1,1 in main group (p&lt;0,05), from 2,9 to 1,3 in comparison group (p&lt;0,05), and from 2,7 to 2,2 in control group (p&lt;0,05). At 12 months, no deaths were registered in main group, with one death in comparison group and 10 deaths in control group (p&lt;0,05). At 12 months, scar volume was 5,7% of left ventricular myocardial mass in main group, 7,5% in comparison group, and 42,3% in control group. Conclusion. Peripheral blood and adipose tissue SC autotransplantation was a highly effective and safe method for acute MI treatment.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>стволовые клетки</kwd><kwd>антитромботическая терапия</kwd><kwd>острый инфаркт миокарда</kwd></kwd-group><kwd-group xml:lang="en"><kwd>stem cells</kwd><kwd>antithrombotic therapy</kwd><kwd>acute myocardial infarction</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Беленков Ю.Н., Агеев Ф.Т., Мареев В.Ю. и др. Мобилизация стволовых клеток костного мозга в лечении больных хронической сердечной недостаточностью. Кардиология 2003; 3: 12-6.</mixed-citation><mixed-citation xml:lang="en">Беленков Ю.Н., Агеев Ф.Т., Мареев В.Ю. и др. Мобилизация стволовых клеток костного мозга в лечении больных хронической сердечной недостаточностью. Кардиология 2003; 3: 12-6.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Беленков Ю.Н., Агеев Ф.Т., Мареев В.Ю. и др. Стволовые клетки и их применение для регенерации миокарда. Ж серд недостат 2003; 4: 168-73.</mixed-citation><mixed-citation xml:lang="en">Беленков Ю.Н., Агеев Ф.Т., Мареев В.Ю. и др. Стволовые клетки и их применение для регенерации миокарда. Ж серд недостат 2003; 4: 168-73.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Владимирская Е.Б., Майорова О.А., Румянцев С.А. и др. Биологические основы и перспективы терапии стволовыми клетками. Москва «Медпрактика-М» 2005; 392 с.</mixed-citation><mixed-citation xml:lang="en">Владимирская Е.Б., Майорова О.А., Румянцев С.А. и др. Биологические основы и перспективы терапии стволовыми клетками. Москва «Медпрактика-М» 2005; 392 с.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Вермель А.Е. Стволовые клетки: общая характеристика и перспективы применения в клинической практике. Клин мед 2004; 1: 5-11.</mixed-citation><mixed-citation xml:lang="en">Вермель А.Е. Стволовые клетки: общая характеристика и перспективы применения в клинической практике. Клин мед 2004; 1: 5-11.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Габбасов З.А., Соболева Э.Л. Стромальные стволовые клетки взрослого организма – резерв восстановительной хирургии. Клин геронт 2003; 5: 20-4.</mixed-citation><mixed-citation xml:lang="en">Габбасов З.А., Соболева Э.Л. Стромальные стволовые клетки взрослого организма – резерв восстановительной хирургии. Клин геронт 2003; 5: 20-4.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Дыбан А.П. Стволовые клетки в экспериментальной и клинической медицине. МАЖ 2002; 3: 3-24.</mixed-citation><mixed-citation xml:lang="en">Дыбан А.П. Стволовые клетки в экспериментальной и клинической медицине. МАЖ 2002; 3: 3-24.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Козлов К.Л. Интервенционная пластика венечных артерий. Санкт-Петербург «ЭЛБИ» 2000; 230 с.</mixed-citation><mixed-citation xml:lang="en">Козлов К.Л. Интервенционная пластика венечных артерий. Санкт-Петербург «ЭЛБИ» 2000; 230 с.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Мушкамбаров Н.Н., Кузнецов С.Л. Молекулярная биология. Москва «ООО Мед информ агентство» 2003; 544 с.</mixed-citation><mixed-citation xml:lang="en">Мушкамбаров Н.Н., Кузнецов С.Л. Молекулярная биология. Москва «ООО Мед информ агентство» 2003; 544 с.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Патофизиология заболеваний сердечно-сосудистой системы. Под ред. Л. Лилли; Пер. с англ. Москва «БИНОМ. Лаборатория знаний» 2003; 598 с.</mixed-citation><mixed-citation xml:lang="en">Патофизиология заболеваний сердечно-сосудистой системы. Под ред. Л. Лилли; Пер. с англ. Москва «БИНОМ. Лаборатория знаний» 2003; 598 с.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Румянцев А.Г., Масчан А.А. Трансплантация гемопоэтических стволовых клеток у детей. Москва «МИА» 2003; 912 с.</mixed-citation><mixed-citation xml:lang="en">Румянцев А.Г., Масчан А.А. Трансплантация гемопоэтических стволовых клеток у детей. Москва «МИА» 2003; 912 с.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Саркисов Д.С. Регенерация и ее клиническое значение. Москва «Медицина» 1979; 284 с.</mixed-citation><mixed-citation xml:lang="en">Саркисов Д.С. Регенерация и ее клиническое значение. Москва «Медицина» 1979; 284 с.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Шахов В.П., Байков А.Н. Стволовые клетки. Реальность и перспективы. Современные аспекты биологии и медицины. Томск «СГУ» 2002; 110-2.</mixed-citation><mixed-citation xml:lang="en">Шахов В.П., Байков А.Н. Стволовые клетки. Реальность и перспективы. Современные аспекты биологии и медицины. Томск «СГУ» 2002; 110-2.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Шахов В.П., Попов С.В. Стволовые клетки и кардиомиогенез в норме и патологии. Томск «STT» 2004; 170 с.</mixed-citation><mixed-citation xml:lang="en">Шахов В.П., Попов С.В. Стволовые клетки и кардиомиогенез в норме и патологии. Томск «STT» 2004; 170 с.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004; 110: e82-292.</mixed-citation><mixed-citation xml:lang="en">Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004; 110: e82-292.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Assmus B, Honold J, Schachinger V, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. NEJM 2006; 355: 1222-32.</mixed-citation><mixed-citation xml:lang="en">Assmus B, Honold J, Schachinger V, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. NEJM 2006; 355: 1222-32.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Assmus B, Schachinger V, Teupe C, et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002; 106: 3009-17.</mixed-citation><mixed-citation xml:lang="en">Assmus B, Schachinger V, Teupe C, et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002; 106: 3009-17.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Bianco P, Robey P. Mesenchymal Stem Cell: clinical applications J Clin Invest 2000; 105: 1663-8.</mixed-citation><mixed-citation xml:lang="en">Bianco P, Robey P. Mesenchymal Stem Cell: clinical applications J Clin Invest 2000; 105: 1663-8.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Britten MB, Abolmaali N, Assmus B, et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction TOPCARE AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 2003; 108: 2212-8.</mixed-citation><mixed-citation xml:lang="en">Britten MB, Abolmaali N, Assmus B, et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction TOPCARE AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 2003; 108: 2212-8.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Essentials of stem cell biology/ Edited by Robert Lanza. Elsevier Academic Press US 2006; 312 p.</mixed-citation><mixed-citation xml:lang="en">Essentials of stem cell biology/ Edited by Robert Lanza. Elsevier Academic Press US 2006; 312 p.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Fernandez-Aviles F, San Roman JA, Garcia-Frade J, et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 2004; 95: 742-8.</mixed-citation><mixed-citation xml:lang="en">Fernandez-Aviles F, San Roman JA, Garcia-Frade J, et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 2004; 95: 742-8.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Janssens S, Dubois C, Bogaert J, et al. Autologous bone marrowderived stemcell transfer in patients with ST-segment elevation myocardial infarction: doubleblind, randomised controlled trial. Lancet 2006; 367: 113-21.</mixed-citation><mixed-citation xml:lang="en">Janssens S, Dubois C, Bogaert J, et al. Autologous bone marrowderived stemcell transfer in patients with ST-segment elevation myocardial infarction: doubleblind, randomised controlled trial. Lancet 2006; 367: 113-21.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Halme DG, Kessler DA. FDA regulation of stem-cell-based therapies. NEJM 2006; 355: 1730-5.</mixed-citation><mixed-citation xml:lang="en">Halme DG, Kessler DA. FDA regulation of stem-cell-based therapies. NEJM 2006; 355: 1730-5.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bonemarrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7: 430-6.</mixed-citation><mixed-citation xml:lang="en">Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bonemarrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7: 430-6.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Lange RA, Hillis LD. Reperfusion therapy in acute myocardial infarction. N Engl J Med 2002; 346: 954-5.</mixed-citation><mixed-citation xml:lang="en">Lange RA, Hillis LD. Reperfusion therapy in acute myocardial infarction. N Engl J Med 2002; 346: 954-5.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Lewis RA. Stem cell legacy: Leroy Stevens; The Scientists, A Stem Cell Legacy. The Scientist 2000; 14: 19-24.</mixed-citation><mixed-citation xml:lang="en">Lewis RA. Stem cell legacy: Leroy Stevens; The Scientists, A Stem Cell Legacy. The Scientist 2000; 14: 19-24.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. NEJM 2006; 355: 1199-209.</mixed-citation><mixed-citation xml:lang="en">Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. NEJM 2006; 355: 1199-209.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003; 9: 1195-201.</mixed-citation><mixed-citation xml:lang="en">Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003; 9: 1195-201.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Okie S. Stem-cell politics. NEJM 2006; 355: 1636-7.</mixed-citation><mixed-citation xml:lang="en">Okie S. Stem-cell politics. NEJM 2006; 355: 1636-7.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Okie S. Single-cell storm. NEJM 2006; 355: 1634-5.</mixed-citation><mixed-citation xml:lang="en">Okie S. Single-cell storm. NEJM 2006; 355: 1634-5.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-5.</mixed-citation><mixed-citation xml:lang="en">Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-5.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Schachinger V, Erbs S, Elsasser A, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. NEJM 2006; 355: 1210-21.</mixed-citation><mixed-citation xml:lang="en">Schachinger V, Erbs S, Elsasser A, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. NEJM 2006; 355: 1210-21.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Schachinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. JACC 2004; 44: 1690-9.</mixed-citation><mixed-citation xml:lang="en">Schachinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. JACC 2004; 44: 1690-9.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Schachinger V, Tonn T, Dimmeler S, Zeiher AM. Bone-marrowderived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial. Nat Clin Pract Cardiovasc Med 2006; 3(Suppl 1): S23-8.</mixed-citation><mixed-citation xml:lang="en">Schachinger V, Tonn T, Dimmeler S, Zeiher AM. Bone-marrowderived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial. Nat Clin Pract Cardiovasc Med 2006; 3(Suppl 1): S23-8.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Schomig A, Kastrati A, Dirschinger J, et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med 2000; 343: 385-91.</mixed-citation><mixed-citation xml:lang="en">Schomig A, Kastrati A, Dirschinger J, et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med 2000; 343: 385-91.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Schwartz RS. The politics and promise of stem-cell research. NEJM 2006; 12: 1189-91.</mixed-citation><mixed-citation xml:lang="en">Schwartz RS. The politics and promise of stem-cell research. NEJM 2006; 12: 1189-91.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Stem cells and the future of regenerative medicine. National Research Council. Institute of medicine. National Academy Press, Washington, DC, US 2002; 47 p.</mixed-citation><mixed-citation xml:lang="en">Stem cells and the future of regenerative medicine. National Research Council. Institute of medicine. National Academy Press, Washington, DC, US 2002; 47 p.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002; 346: 957-66.</mixed-citation><mixed-citation xml:lang="en">Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002; 346: 957-66.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106: 1913-8.</mixed-citation><mixed-citation xml:lang="en">Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106: 1913-8.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004; 364: 141-8.</mixed-citation><mixed-citation xml:lang="en">Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004; 364: 141-8.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
